Adenocarcinoma is one of the most common pathologic types of PCa, and past studies have pointed to MYC as a major driver of prostate adenocarcinoma occurrence and progression (Surintrspanont, Zhou 2022). The gene discussed is MYC; the disease is adenocarcinoma.